The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Researchers Find the Switch that Underlies Macrophage Metabolism

Researchers Find the Switch that Underlies Macrophage Metabolism

March 28, 2016 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

GENERIC_Science_Research_500x270The immune system develops its complexity via a strictly coordinated nutrient metabolism and bioenergetics. Mature immune cells must be capable of two functions that require a great deal of bioenergetic support: entering the cell cycle upon stimulation by a mitogen and producing bactericidal factors. Although both actions demand heightened metabolic activity, they tend to occur at mutually exclusive times. During inflammation, immune cells must rapidly adjust their metabolic activity in response to environmental cues.

You Might Also Like
  • Researchers Target Altered T Cell Metabolism in SLE to Reverse Lupus Immuno-Phenotype
  • FOCIS 2015: Metabolism May Affect Immune System’s Reaction to Disease
  • 2015 ACR/ARHP Annual Meeting: Macrophage Polarization and Its Role in Inflammatory Disease
Also By This Author
  • Liquid Biopsy Provides Insights into Lupus

Macrophages, in particular, must maintain homeostatic proliferation in the presence of mitogens, such as colony stimulating factor-1 (CSF-1), while at the same time being able to engage in a rapid pro-inflammatory response to invading microorganisms. Such a cell fate change requires extensive reprogramming of the metabolism. This reprogramming can be seen when macrophages are treated with different stimuli. For example, macrophages treated with the mitogen CSF-1 respond with a time-dependent, up-regulation of glycolysis. The resulting rapid proliferation, as well as the heightened glycolysis, is similar to what is seen in tumor cells.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In contrast, when macrophages are given a pro-inflammatory stimulus, they rely on glucose catabolism, largely via aerobic glycolysis and the pentose phosphate pathway that runs parallel to glycolysis. Research suggests that the ability to make this metabolic switch is critical for the host-defense properties of macrophages. Further investigation into the switch has revealed two important transcription factors: the myelocytomatosis viral oncogene (Myc) up-regulates glucose and glucamine catabolism, and the transcription hypoxia-inducible factor alpha (HIF1α) regulates glycolysis. Interestingly, these transcription factors appear to play a role in metabolic switching in both immune cells and cancer cells. Additionally, research has indicated that Myc plays an important role in the CSF-1-induced mitogenic response in macrophages. However, up until now, further insights into the regulatory mechanisms behind the metabolic switch have remained elusive.

Lingling Liu, PhD, a research scientist at Ohio State University in Columbus, and colleagues published the results of their metabolic analysis online Feb. 9 in the Proceedings of the National Academy of Sciences.1 The investigators focused their research on macrophages and the distinct transcriptional programs that are engaged in response to mitogenic and pro-inflammatory stimulation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers asked whether up-regulation of Myc is required for CSF-1-driven rewiring in macrophages. To address this question, they deleted either Myc or HIF1α and found they were able to selectively impair the corresponding CSF-1- or lipopolysaccharide (LPS)-driven metabolic activities of bone marrow-derived macrophages (BMDM).

Closer examination of the pro-inflammatory response revealed that stimulation of macrophages with LPS plus interferon (IFN) ɣ resulted in an up-regulation of glycolysis, as well as the increased expression of glycolytic genes. Additionally, when the investigators inhibited glycolysis in vivo either via treatment with the pharmacological agent 2-deoxyglucose (2-DG) or via genetic deletion of HIF1α, they were able to suppress LPS-induced inflammation. Likewise, when they blocked glycolysis with 2-DG, they were able to protect mice against lethal endotoxemia. Thus, HIF1α—but not Myc—is required for the regulation of glycolysis in macrophages given pro-inflammatory stimulation.

Pages: 1 2 | Single Page

Filed Under: Conditions, Research Reviews Tagged With: inflammation, macrophages, metabolism

You Might Also Like:
  • Researchers Target Altered T Cell Metabolism in SLE to Reverse Lupus Immuno-Phenotype
  • FOCIS 2015: Metabolism May Affect Immune System’s Reaction to Disease
  • 2015 ACR/ARHP Annual Meeting: Macrophage Polarization and Its Role in Inflammatory Disease
  • Gout, Glucose Metabolism and Obesity: A Case Review

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)